Skip to search formSkip to main contentSkip to account menu

fingolimod

Known as: Fingolimodum 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (3)

FTY-720Gilenyafingolimod hydrochloride
fingolimod 0.5 MG Oral Capsule [Gilenya]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
Fingolimod approval was based mainly on two clinical trials, FREEDOMS and TRANSFORMS, which demonstrated the efficacy and safety… 
2015
2015
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab…
Natalizumab discontinuation induces the recurrence of multiple sclerosis disease activity: currently no therapeutic approach has… 
Highly Cited
2014
Highly Cited
2014
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
Background Approximately one-third of patients with multiple sclerosis (MS) are unresponsive to, or intolerant of, interferon… 
2014
2014
Engage with research participants about social media
A growing number of participants in clinical trials are sharing information about their health online. It's time that the drug… 
Review
2013
Review
2013
Fingolimod Therapy for Multiple Sclerosis
Abstract Because of its potent efficacy and oral route of administration, the approval of fingolimod as treatment for relapsing… 
2013
2013
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis
Abstract Objective: Disease-modifying therapies, such as fingolimod, interferon (IFN) and glatiramer acetate (GA), have differing… 
Review
2012
Review
2012
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.
2012
2012
The monocyte in atherosclerosis--should I stay or should I go now?
The accrual of cholesterol-laden macrophages in the atherosclerotic plaque is a critical event that precedes plaque rupture. The… 
Review
2008
Review
2008
Sphingosine 1-phosphate chemical biology.
Review
2007
Review
2007
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
FTY720 (fingolimod; 2-amino-2[2-(4-octylphenyl)ethyl]-1,3-propanediol, Novartis) is the prototype of a new generation of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)